--- schema_version: "secwatch.filing_event.v1" accession: "0001628280-24-014887" form_type: "8-K" ticker: "SOLV" cik: "0001964738" company_name: "Solventum Corp" filed_at: "2024-04-04T23:59:59+00:00" generated_at: "2026-06-04T02:32:32.048440+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.9 calibrated_materiality_score: 0.9 confidence: "high" source: SEC EDGAR --- # Solventum completes 3M spin-off, begins trading on NYSE as SOLV ## Summary - 80.1% of Solventum shares distributed to 3M stockholders on April 1, 2024; spin-off effective 3:30 a.m. ET. - Solventum reported $8.2B sales in 2023; employs 22,000 people across four business segments. - New executive team: CEO Bryan Hanson, CFO Wayde McMillan, board chair Carrie Cox. - Board reconstituted to 11 members with four committees (Audit, Governance, Talent, Science/Quality). - Separation agreements signed with 3M covering transition services, tax, IP, supply, and trademarks. ## SEC filing metadata - accession: 0001628280-24-014887 - form_type: 8-K - ticker: SOLV - cik: 0001964738 - company_name: Solventum Corp - filed_at: 2024-04-04T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.9 - calibrated_materiality_score: 0.9 - confidence: high - sec_items: 1.01, 3.03, 5.03, 5.02, 5.05, 8.01, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/solventum-closing8xk4324.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001628280-24-014887 - JSON: https://secwatch.observer/filing/0001628280-24-014887.json - Plain text: https://secwatch.observer/filing/0001628280-24-014887.txt ## Key facts - Executive change Paul Harrington was appointed as Chief Supply Chain Officer at Solventum Corp. - Action: appointed - Role: Chief Supply Chain Officer source text: Paul Harrington Chief Supply Chain Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Executive change Marcela Kirberger was appointed as Chief Legal Affairs Officer, Corporate Secretary at Solventum Corp. - Action: appointed - Role: Chief Legal Affairs Officer, Corporate Secretary source text: Marcela Kirberger Chief Legal Affairs Officer, Corporate Secretary evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Executive change Tammy Gomez was appointed as Chief Human Resources Officer at Solventum Corp. - Action: appointed - Role: Chief Human Resources Officer source text: Tammy Gomez Chief Human Resources Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Executive change Mary Wilcox was appointed as Senior Vice President, Controller and Chief Accounting Officer at Solventum Corp. - Action: appointed - Role: Senior Vice President, Controller and Chief Accounting Officer source text: Mary Wilcox Senior Vice President, Controller and Chief Accounting Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Executive change Amy Landucci was appointed as Chief Information and Digital Officer at Solventum Corp. - Action: appointed - Role: Chief Information and Digital Officer source text: Amy Landucci Chief Information and Digital Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Executive change Bryan Hanson was appointed as Chief Executive Officer at Solventum Corp. - Action: appointed - Role: Chief Executive Officer source text: Bryan Hanson Chief Executive Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Executive change Chris Barry was appointed as Executive Vice President and Group President, Medical Solutions at Solventum Corp. - Action: appointed - Role: Executive Vice President and Group President, Medical Solutions source text: Chris Barry Executive Vice President and Group President, Medical Solutions evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Executive change Wayde McMillan was appointed as Chief Financial Officer at Solventum Corp. - Action: appointed - Role: Chief Financial Officer source text: Wayde McMillan Chief Financial Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Governance Changes Solventum Corp: Adoption of Corporate Governance Guidelines and Board of Directors Code of Business Conduct and Ethics. - Change: code of ethics source text: In connection with the Distribution, the Board adopted Corporate Governance Guidelines and a Board of Directors Code of Business Conduct and Ethics, effective as of the Effective Time. evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Governance Changes Solventum Corp: Amended and restated Certificate of Incorporation effective March 31, 2024 (effective 2024-03-31). - Change: charter amendment - Effective: 2024-03-31 source text: Effective as of 3:30 a.m. Eastern Time on March 31, 2024, Solventum amended and restated its Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”) evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Governance Changes Solventum Corp: Amended and restated Bylaws effective March 31, 2024 (effective 2024-03-31). - Change: bylaw amendment - Effective: 2024-03-31 source text: immediately thereafter, amended and restated its Bylaws (the “Amended and Restated Bylaws”) evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm - Material Agreements Solventum Corp entered into Separation and Distribution Agreement and related agreements with 3M Company valued at Entry into multiple separation-related agreements including Separation and Distribution Agreement, T (effective 2024-03-31). - Action: entry - Agreement: supply - Counterparty: 3M Company - Value: Entry into multiple separation-related agreements including Separation and Distribution Agreement, T - Effective: 2024-03-31 source text: On March 31, 2024, Solventum Corporation (“Solventum”) entered into several agreements with 3M Company (“3M”) in connection with the spin-off of 3M’s health care business (the “Separation”) through the pro rata distribution of 80.1% of the issued and outstanding shares of common stock, par value $0.01 per share, of Solventum to 3M’s stockholders of record as of the close of business on March 18, 2024 (the “Distribution”). evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.